chitosan has been researched along with Gastric Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Galdioli Pellá, MC; Lima-Tenório, MK; Nakamura, CV; Rubira, AF; Scariot, DB; Simão, AR; Tenório-Neto, E | 1 |
| Boontawee, R; Issarachot, O; Kaewkroek, K; Wiwattanapatapee, R | 1 |
| Abbasi, R; Ihsan, A; Imran, M; Niaz, T; Noor, T; Shabbir, S | 1 |
3 other study(ies) available for chitosan and Gastric Diseases
| Article | Year |
|---|---|
Chitosan hybrid microgels for oral drug delivery.
Topics: Administration, Oral; Cell Survival; Chitosan; Drug Delivery Systems; HT29 Cells; Humans; Hydrogen-Ion Concentration; Microgels; Nanoparticles; Particle Size; Silanes; Silicon Dioxide; Stomach Diseases; Surface Properties; Vitamin B 12 | 2020 |
Foldable/Expandable Gastro-retentive Films Based on Starch and Chitosan as a Carrier For Prolonged Release of Resveratrol.
Topics: Animals; Capsules; Chitosan; Excipients; Humans; Mice; Polymers; Resveratrol; Solubility; Solvents; Starch; Stomach Diseases | 2022 |
Chitosan-albumin based core shell-corona nano-antimicrobials to eradicate resistant gastric pathogen.
Topics: Anti-Infective Agents; Chemical Phenomena; Chitosan; Drug Carriers; Drug Delivery Systems; Gastric Mucosa; Microbial Sensitivity Tests; Nanocomposites; Particle Size; Serum Albumin, Bovine; Stomach Diseases | 2019 |